Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OnabotulinumtoxinA for Erectile Dysfunction Refractory to PDE5 Inhibitors
NCT07834164Phase 2Completed
- Sponsor
- Universidad de Navarra
- Start
- Nov 2024
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in erectile dysfunction (ED), sponsored by Universidad de Navarra. Started Nov 2024; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT07834164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07834164.